In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
Yoshioka H, Yamamoto S, Hanaoka H, Iida Y, Paudyal P, Higuchi T, Tominaga H, Oriuchi N, Nakagawa H, Shiba Y, et al. Cancer Immunol Immunother. 2012 Aug; 61(8):1211-20. Epub 2012 Jan 6.